2024 |
04/23 | 82 | 85 | 82 | 83 | +1.22% | 117,300 | 29億8982万 | -4.6% |
04/22 | 81 | 83 | 80 | 82 | +1.23% | 111,500 | 29億2693万 | -5.75% |
04/19 | 81 | 82 | 79 | 81 | -1.22% | 263,500 | 28億9124万 | -7.95% |
04/19 | (空売り報告)JPM Securities Japan Co Ltd. 250,100株(0.69%)-0.08% |
04/19 | (空売り報告)UBS AG 258,600株(0.71%)+0.08% |
04/18 | 81 | 83 | 81 | 82 | +1.23% | 141,100 | 29億2693万 | -6.82% |
04/17 | 83 | 83 | 81 | 81 | -2.41% | 233,000 | 28億9124万 | -8.99% |
04/16 | 83 | 83 | 81 | 83 | +1.22% | 223,300 | 29億6263万 | -6.74% |
04/16 | (空売り報告)JPM Securities Japan Co Ltd. 279,600株(0.77%)-0.12% |
04/16 | (空売り報告)UBS AG 230,400株(0.63%)+0.04% |
04/15 | (IR情報)15:00 ファシリティ契約に基づく第17回新株予約権(行使価額修正条項付)の行使停止要請に関するお知らせ |
04/15 | 82 | 84 | 82 | 82 | -2.38% | 234,300 | 29億2693万 | -8.89% |
04/15 | (空売り報告)UBS AG 215,400株(0.59%)-0.06% |
04/12 | 85 | 87 | 84 | 84 | -2.33% | 366,400 | 29億9832万 | -7.69% |
04/11 | 87 | 88 | 86 | 86 | -1.15% | 132,800 | 30億6971万 | -5.49% |
04/11 | (空売り報告)XTX Markets Pte Ltd 212,300株(0.58%)再IN |
04/10 | 87 | 89 | 87 | 87 | -1.14% | 113,400 | 31億540万 | -5.43% |
04/10 | (空売り報告)JPM Securities Japan Co Ltd. 321,800株(0.89%)-0.08% |
04/10 | (空売り報告)UBS AG 235,400株(0.65%)-0.11% |
04/09 | 87 | 88 | 86 | 88 | +1.15% | 205,700 | 31億4110万 | -4.35% |
04/09 | (空売り報告)XTX Markets Pte Ltd 178,400株(0.49%)-0.01%義務消失 |
04/08 | (IR情報)15:00 JST・CREST「AIアプタマー創薬プロジェクト」の高評価にもとづく追加支援採択のお知らせ |
04/08 | 88 | 88 | 84 | 87 | +1.16% | 307,700 | 31億540万 | -6.45% |
04/08 | (空売り報告)XTX Markets Pte Ltd 183,600株(0.5%)再IN |
04/05 | 87 | 88 | 86 | 86 | -1.15% | 247,400 | 30億6971万 | -7.53% |
04/05 | (空売り報告)JPM Securities Japan Co Ltd. 352,200株(0.97%)-0.09% |
04/04 | 89 | 89 | 87 | 87 | -1.14% | 183,800 | 31億540万 | -7.45% |
04/03 | 88 | 89 | 86 | 88 | 0% | 305,900 | 31億4110万 | -6.38% |
04/03 | (空売り報告)UBS AG 275,900株(0.76%)+0.07% |
04/02 | (5%ルール)SMBC日興証券(19.41%) |
04/02 | 90 | 90 | 88 | 88 | -3.3% | 200,400 | 31億4110万 | -7.37% |
04/02 | (空売り報告)UBS AG 250,400株(0.69%)+0.1% |
04/01 | (IR情報)15:00 第17回新株予約権(行使価額修正条項付)の月間行使状況に関するお知らせ |
04/01 | 92 | 93 | 90 | 91 | -2.15% | 286,400 | 32億4818万 | -4.21% |
04/01 | (空売り報告)JPM Securities Japan Co Ltd. 382,900株(1.06%)-0.08% |
04/01 | (空売り報告)UBS AG 212,800株(0.59%)-0.14% |
03/29 | 94 | 95 | 92 | 93 | 0% | 286,000 | 33億1957万 | -2.11% |
03/29 | (空売り報告)UBS AG 263,500株(0.73%)-0.08% |
03/28 | 90 | 101 | 89 | 93 | +2.2% | 1,018,400 | 33億1957万 | -3.13% |
03/28 | (空売り報告)JPM Securities Japan Co Ltd. 407,300株(1.14%)-0.07% |
03/28 | (空売り報告)UBS AG 289,300株(0.81%)+0.05% |
03/27 | 88 | 91 | 88 | 91 | +3.41% | 277,400 | 32億4818万 | -5.21% |
03/26 | 89 | 89 | 88 | 88 | -1.12% | 132,900 | 31億4110万 | -9.28% |
03/25 | 90 | 91 | 88 | 89 | -1.11% | 405,800 | 31億7679万 | -8.25% |
03/25 | (空売り報告)UBS AG 274,800株(0.76%)再IN |
03/22 | 91 | 91 | 90 | 90 | -1.1% | 248,500 | 32億1249万 | -8.16% |
03/21 | 92 | 92 | 91 | 91 | -1.09% | 165,600 | 32億4818万 | -7.14% |
03/19 | 92 | 93 | 90 | 92 | 0% | 431,100 | 32億8387万 | -6.12% |
03/19 | (空売り報告)JPM Securities Japan Co Ltd. 433,000株(1.21%)+0.09% |
03/18 | 93 | 94 | 92 | 92 | -2.13% | 198,700 | 32億8387万 | -7.07% |
03/15 | 93 | 95 | 93 | 94 | -1.05% | 177,900 | 33億5526万 | -5.05% |
03/14 | (5%ルール)SMBC日興証券(20.67%) |
03/14 | 95 | 96 | 93 | 95 | 0% | 279,300 | 33億9096万 | -5% |
03/14 | (空売り報告)JPM Securities Japan Co Ltd. 401,700株(1.12%)+0.11% |
03/13 | 97 | 97 | 95 | 95 | -2.06% | 302,200 | 33億9096万 | -5% |
03/12 | 95 | 97 | 95 | 97 | 0% | 122,300 | 34億6235万 | -3.96% |
03/11 | (IR情報)15:11 AI(人工知能)を利用した新型コロナウイルスに対するアプタマー論文採択と東京大学医科学研究所アジア感染症研究拠点との共同研究終了のお知らせ |
03/11 | 97 | 98 | 95 | 97 | -1.02% | 277,300 | 34億6235万 | -3.96% |
03/11 | (空売り報告)JPM Securities Japan Co Ltd. 361,700株(1.01%)+0.02% |
03/08 | 97 | 99 | 97 | 98 | 0% | 166,900 | 34億9804万 | -2.97% |
03/07 | (IR情報)15:00 第三者割当による第17回新株予約権(行使価額修正条項付)の発行に係る払込完了に関するお知らせ |
03/07 | 99 | 100 | 97 | 98 | -1.01% | 184,400 | 34億9804万 | -2.97% |
03/07 | (空売り報告)JPM Securities Japan Co Ltd. 354,900株(0.99%)-0.01% |
03/06 | 97 | 100 | 97 | 99 | +2.06% | 176,500 | 35億3373万 | -2.94% |
03/05 | 98 | 98 | 96 | 97 | -2.02% | 210,500 | 34億6235万 | -4.9% |
03/04 | 99 | 101 | 98 | 99 | -1% | 184,800 | 35億3373万 | -2.94% |
03/04 | (空売り報告)JPM Securities Japan Co Ltd. 357,500株(1%)+0.07% |
03/01 | 101 | 101 | 99 | 100 | -1.96% | 113,300 | 35億6943万 | -2.91% |
02/29 | 103 | 103 | 100 | 102 | -0.97% | 137,200 | 36億4082万 | -0.97% |
02/28 | 99 | 104 | 99 | 103 | +4.04% | 388,600 | 36億7651万 | 0% |
02/27 | 99 | 101 | 98 | 99 | +1.02% | 140,800 | 35億3373万 | -4.81% |
02/26 | 96 | 100 | 95 | 98 | +3.16% | 273,800 | 34億9804万 | -5.77% |
02/22 | 100 | 100 | 95 | 95 | -5% | 898,400 | 33億9096万 | -8.65% |
02/22 | (空売り報告)JPM Securities Japan Co Ltd. 333,900株(0.93%)再IN |
02/21 | 102 | 102 | 99 | 100 | -7.41% | 518,000 | 35億6943万 | -4.76% |
02/20 | (IR情報)15:30 第三者割当による第17回新株予約権(行使価額修正条項付)の発行及びファシリティ契約(行使停止指定条項付)の締結に関する補足説明資料 |
02/20 | (IR情報)15:30 第三者割当による第17回新株予約権(行使価額修正条項付)の発行及びファシリティ契約(行使停止指定条項付)の締結に関するお知らせ |
02/20 | (IR情報)15:30 第三者割当による第15回新株予約権及び第16回新株予約権に係る資金使途及び支出予定時期の変更に関するお知らせ |
02/20 | 103 | 108 | 103 | 108 | +5.88% | 257,500 | 38億5498万 | +2.86% |
02/19 | 102 | 104 | 102 | 102 | +0.99% | 159,400 | 36億4082万 | -2.86% |
02/16 | 98 | 102 | 97 | 101 | +3.06% | 179,500 | 36億512万 | -4.72% |
02/15 | 99 | 100 | 97 | 98 | -1.01% | 286,600 | 34億9804万 | -7.55% |
02/14 | 102 | 102 | 99 | 99 | -1.98% | 193,600 | 35億3373万 | -7.48% |
02/13 | (IR情報)15:00 営業外損失(為替差損)の計上に関するお知らせ |
02/13 | (IR情報)15:00 2024年3月期第3四半期決算短信〔日本基準〕(非連結) |
02/13 | 102 | 104 | 101 | 101 | -1.94% | 147,600 | 36億512万 | -5.61% |
02/09 | 102 | 104 | 102 | 103 | -0.96% | 91,800 | 36億7651万 | -3.74% |
02/08 | 102 | 104 | 101 | 104 | 0% | 247,700 | 37億1221万 | -3.7% |
02/07 | 106 | 106 | 103 | 104 | -1.89% | 162,800 | 37億1221万 | -3.7% |
02/06 | 107 | 108 | 104 | 106 | +0.95% | 131,200 | 37億8360万 | -1.85% |
02/05 | (IR情報)15:00 リボミックと北海道大学とのANCA関連血管炎に関する共同研究契約締結のお知らせ |
02/05 | 104 | 107 | 102 | 105 | +2.94% | 183,200 | 37億4790万 | -2.78% |
02/02 | 103 | 104 | 102 | 102 | -1.92% | 146,000 | 36億4082万 | -4.67% |
02/01 | 105 | 106 | 102 | 104 | -0.95% | 194,200 | 37億1221万 | -2.8% |
01/31 | 107 | 107 | 104 | 105 | -1.87% | 129,600 | 37億4790万 | -1.87% |
01/30 | 107 | 108 | 107 | 107 | -0.93% | 107,000 | 38億1929万 | 0% |
01/29 | 109 | 109 | 107 | 108 | -0.92% | 109,500 | 38億5498万 | +1.89% |
01/26 | 107 | 111 | 107 | 109 | +0.93% | 270,000 | 38億9068万 | +2.83% |
01/25 | 109 | 110 | 107 | 108 | -0.92% | 142,600 | 38億5498万 | +1.89% |
01/24 | 107 | 111 | 107 | 109 | +0.93% | 120,000 | 38億9068万 | +2.83% |
01/23 | 108 | 111 | 107 | 108 | +1.89% | 372,900 | 38億5498万 | +1.89% |
01/22 | 106 | 108 | 105 | 106 | +0.95% | 160,300 | 37億8360万 | +0.95% |
01/19 | 105 | 109 | 105 | 105 | -0.94% | 304,400 | 37億4790万 | 0% |
01/18 | 109 | 109 | 106 | 106 | -2.75% | 272,200 | 37億8360万 | 0% |
01/17 | 120 | 120 | 107 | 109 | -6.84% | 1,666,500 | 38億9068万 | +2.83% |
01/16 | 110 | 121 | 110 | 117 | +7.34% | 1,129,800 | 41億7623万 | +10.38% |
01/15 | 111 | 111 | 109 | 109 | 0% | 243,200 | 38億9068万 | +2.83% |
01/12 | 111 | 112 | 107 | 109 | -1.8% | 303,700 | 38億9068万 | +1.87% |
01/11 | 112 | 115 | 111 | 111 | +0.91% | 149,400 | 39億6207万 | +3.74% |
01/10 | 113 | 114 | 110 | 110 | -2.65% | 139,600 | 39億2637万 | +1.85% |
01/09 | 111 | 113 | 110 | 113 | +2.73% | 223,000 | 40億3346万 | +4.63% |
01/05 | 111 | 112 | 110 | 110 | -1.79% | 223,900 | 39億2637万 | +0.92% |
01/04 | 104 | 112 | 104 | 112 | +3.7% | 346,600 | 39億9776万 | +2.75% |
2023 |
12/29 | 104 | 108 | 104 | 108 | +2.86% | 319,400 | 38億5498万 | -0.92% |
12/28 | 97 | 106 | 97 | 105 | +9.38% | 828,200 | 37億4790万 | -4.55% |
12/28 | (空売り報告)GOLDMAN SACHS INTERNATIONAL 167,753株(0.46%)-0.11%義務消失 |
12/27 | 95 | 99 | 94 | 96 | +1.05% | 1,056,300 | 34億2665万 | -12.73% |
12/27 | (空売り報告)XTX Markets Pte Ltd 102,200株(0.28%)-0.39%義務消失 |
12/27 | (空売り報告)UBS AG 127,600株(0.35%)-0.33%義務消失 |
12/27 | (空売り報告)GOLDMAN SACHS INTERNATIONAL 206,553株(0.57%)-0.12% |
12/26 | 106 | 107 | 94 | 95 | -3.06% | 3,177,700 | 33億9096万 | -14.41% |
12/26 | (空売り報告)XTX Markets Pte Ltd 241,200株(0.67%)新規 |
12/26 | (空売り報告)UBS AG 244,100株(0.68%)再IN |
12/25 | 98 | 100 | 97 | 98 | 0% | 690,000 | 34億9804万 | -12.5% |
12/22 | 109 | 109 | 98 | 98 | -1.01% | 1,770,600 | 34億9804万 | -13.27% |
12/21 | (IR情報)19:00 軟骨無形成症治療薬(umedaptanib pegol)の前期第II相長期投与試験開始のお知らせ |
12/21 | 104 | 104 | 99 | 99 | -2.94% | 692,700 | 35億3373万 | -13.16% |
12/20 | 105 | 107 | 101 | 102 | -3.77% | 1,089,600 | 36億4082万 | -11.3% |
12/20 | (空売り報告)GOLDMAN SACHS INTERNATIONAL 246,953株(0.69%)-0.02% |
12/19 | 99 | 113 | 98 | 106 | +8.16% | 3,379,700 | 37億8360万 | -7.83% |
12/18 | 103 | 103 | 95 | 98 | -4.85% | 741,700 | 34億9804万 | -15.52% |
12/15 | 105 | 106 | 99 | 103 | -1.9% | 644,300 | 36億7651万 | -11.21% |
12/14 | 107 | 109 | 105 | 105 | -0.94% | 153,400 | 37億4790万 | -10.26% |
12/13 | 105 | 109 | 105 | 106 | +0.95% | 296,700 | 37億8360万 | -10.17% |
12/12 | 112 | 113 | 105 | 105 | -6.25% | 621,100 | 37億4790万 | -11.76% |
12/11 | 114 | 115 | 112 | 112 | -2.61% | 253,800 | 39億9776万 | -5.88% |
12/08 | 116 | 116 | 113 | 115 | -1.71% | 263,800 | 41億484万 | -4.17% |
12/08 | (空売り報告)GOLDMAN SACHS INTERNATIONAL 253,953株(0.71%)+0.02% |
12/07 | 120 | 120 | 117 | 117 | -2.5% | 143,900 | 41億7623万 | -2.5% |
12/07 | (空売り報告)GOLDMAN SACHS INTERNATIONAL 248,253株(0.69%)-0.01% |
12/06 | (IR情報)15:00 金融・経済ウェブメディアZUU online及びNET MONEYにて、弊社2024年3月期第2四半期決算説明会のサマリー記事が掲載されました |
12/06 | 120 | 120 | 118 | 120 | 0% | 118,100 | 42億8332万 | 0% |
12/05 | 118 | 120 | 118 | 120 | +1.69% | 181,900 | 42億8332万 | 0% |
12/05 | (空売り報告)GOLDMAN SACHS INTERNATIONAL 250,653株(0.7%)+0.04% |
12/04 | (IR情報)15:00 滲出型加齢黄斑変性に対するumedaptanib pegolの臨床POCに関する論文掲載のお知らせ |
12/04 | 118 | 120 | 118 | 118 | +0.85% | 149,500 | 42億1193万 | -2.48% |
12/01 | 124 | 124 | 117 | 117 | -4.1% | 507,100 | 41億7623万 | -3.31% |
11/30 | 126 | 126 | 122 | 122 | -3.94% | 231,400 | 43億5470万 | 0% |
11/29 | 120 | 129 | 120 | 127 | +5.83% | 631,000 | 45億3318万 | +4.1% |
11/28 | 120 | 122 | 119 | 120 | 0% | 112,400 | 42億8332万 | -1.64% |
11/27 | 120 | 123 | 118 | 120 | -0.83% | 261,100 | 42億8332万 | -1.64% |